Daniel Unić

Daniel Unić

Auto-generated profile, based on publicly available information

Daniel Unić

Department of Cardiac and Transplant Surgery, University Hospital Dubrava , Zagreb

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2025 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
OSOsama Soliman
Osama Soliman
EHElfatih A. Hasabo
Elfatih A. Hasabo
NRNiels Van Royen
Niels Van Royen
Ignacio J. Amat-SantosIgnacio J. Amat-Santos
Ignacio J. Amat-Santos
MHMartin Hudec
Martin Hudec
ABAndreas Baumbach
Andreas Baumbach
Aims: Several factors, including device design, annulus size, and sizing strategies, influence transcatheter heart valve (THV) haemodynamic outcomes in patients with aortic stenosis (AS). This sub-study evaluates early (30-day) echocardiographic outcomes of the Myval, Sapien, and Evolut THV series, focusing on haemodynamic performance and valve durability. Methods and results: The LANDMARK trial is a prospective, randomised, multicentre, open-label, non-inferiority trial comparing 384 patients implanted with Myval THV series to 384 receiving Sapien and Evolut THV series. Haemodynamic assessments followed Valve Academic Research Consortium-3 recommendations. At 30-day, haemodynamic device success rates were 85.9%, 77.8, and 85.4% for Myval, Sapien, and Evolut THV series, respectively (PMyval-Sapien = 0.03 and PMyval-Evolut = 0.98). Significant improvements in peak aortic flow velocity, pressure gradients, effective orifice area (EOA), Doppler velocity index (DVI), and cardiac indices were observed across all groups, except for unchanged left ventricular ejection fraction. Moderate prosthesis-patient mismatch (PPM) was less frequent with Myval THV series(11.3%) vs. Sapien THV series(21.8%), but higher than Evolut THV series (5.3%) (PMyval-Sapien = 0.0024, PMyval-Evolut = 0.0396), while severe PPM showed no significant differences (4.2% vs. 6.3% vs. 1.8%; PMyval-Sapien = 0.394, PMyval-Evolut = 0.2438). Rates of ≥ moderate paravalvular leak (PVL) were lower in Myval (3.5%), and Sapien (1.7%) compared with Evolut THV series (8.3%) (PMyval-Sapien = 0.3769, PMyval-Evolut = 0.0336). Myval THV series required minimal oversizing compared with Evolut THV series (P < 0.0001). Conclusion: The Myval THV series demonstrates short-term haemodynamic performance comparable to Evolut THV series and superior to Sapien THV series. Including intermediate sizes minimizes oversizing, underscoring its potential as an alternative for TAVI patients. Long-term follow-up is necessary to confirm these findings. Clinical trial registration: ClinicalTrials.gov: NCT04275726, EudraCT number 2020-000,137-40

1 August 2005 in ACC Current Journal Review
Verified
Journal Article
Closed access
MLM. Leacche
M. Leacche
DUD. Unic
D. Unic
SGS.Z. Goldhaber
S.Z. Goldhaber

1 January 2021 in Cardiologia Croatica
Verified
Journal Article
Closed access
IHIrzal Hadžibegović
Irzal Hadžibegović
DUDanijel Unić
Danijel Unić
IJIvana Jurin
Ivana Jurin
NBNikola Bradić
Nikola Bradić
BSBoris Starčević
Boris Starčević
IRIgor Rudez
Igor Rudez

1 November 2017 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
PDF file
FRFranjo Rudman
Franjo Rudman
DBDavor Barić
Davor Barić
DUDaniel Unić
Daniel Unić
Omentum flap as a salvage procedure in deep sternal wound infection Franjo Rudman,1 Davor BariÄ?,2 Daniel UniÄ?2 1Department of Plastic, Reconstructive and Aesthetic Surgery, University Hospital â??Dubravaâ??, 2Department of Cardiac and Transplant Surgery, University Hospital â??Dubravaâ??, Zagreb, CroatiaWe read with great interest the report by Dr Spindler and coworkers about the utilization of omentoplasty as salvage procedure in deep sternal wound infection.1 First of all, we congratulate the authors on the excellent results. Mortality rates in this high-risk cohort of patients can be attributed to advanced age, comorbidities, and other complications, but neither the timing nor the type of reconstruction performed.View the original paper by Spindler and colleagues.

5 July 2015 in Cardiologia Croatica
Verified
Journal Article
Closed access
JMJure Mirat
Jure Mirat
IAIgor Alfirevic
Igor Alfirevic
SBStjepan Barisin
Stjepan Barisin
RBRobert Bernat
Robert Bernat
BBBojan Biocina
Bojan Biocina
JVJakov Vojkovic
Jakov Vojkovic

1 November 2022 in Cardiologia Croatica
Verified
Journal Article
Closed access
MUMario Udovicic
Mario Udovicic
NPNika Barbara Pravica
Nika Barbara Pravica
MSMihovil Santini
Mihovil Santini
DGDanijela Grizelj
Danijela Grizelj
VMVanja Ivanović Mihajlović
Vanja Ivanović Mihajlović
ŠMŠime Manola
Šime Manola